Biophytis SA
PAR:ALBPS

Watchlist Manager
Biophytis SA Logo
Biophytis SA
PAR:ALBPS
Watchlist
Price: 0.0638 EUR 4.42% Market Closed
Market Cap: 2.5m EUR

Relative Value

There is not enough data to reliably calculate the relative value of ALBPS.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALBPS Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.2
Forward
1.6
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-14.1
Industry
24.2
Forward
-0.2
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-17.4
Industry
23
vs History
vs Industry
Median 3Y
-3
Median 5Y
-18.2
Industry
25.5
vs History
vs Industry
Median 3Y
-3.4
Median 5Y
-0.8
Industry
3.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.6
Forward
2.7
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.5
vs History
vs Industry
28
Median 3Y
-1.9
Median 5Y
-15.9
Industry
6.1
Forward
-0.5
vs History
vs Industry
26
Median 3Y
-1.8
Median 5Y
-15.4
Industry
6.6
Forward
-0.5
vs History
vs Industry
30
Median 3Y
-1.9
Median 5Y
-17
Industry
8.8
vs History
vs Industry
26
Median 3Y
-1.9
Median 5Y
-16.9
Industry
6.8
vs History
93
vs Industry
53
Median 3Y
8.1
Median 5Y
94.9
Industry
5.7

Multiples Across Competitors

ALBPS Competitors Multiples
Biophytis SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Biophytis SA
PAR:ALBPS
2.5m EUR 0 -0.3 -0.6 -0.5
IL
Can Fite Biopharma Ltd
TASE:CANF
159.8T ILS 57 882 330.4 -3 974 986 -3 900 678.1 -3 891 995.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 067 817 -161 919.3 -196 621.7 -194 378
US
Abbvie Inc
NYSE:ABBV
389.4B USD 6.5 165.8 16.1 22.9
US
Amgen Inc
NASDAQ:AMGN
173.9B USD 4.8 24.8 18 18
US
Gilead Sciences Inc
NASDAQ:GILD
150.5B USD 5.2 18.6 12.5 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.7B USD 10 32 23.5 24.6
US
Epizyme Inc
F:EPE
94.1B EUR 2 067.9 -527.7 -574.6 -559.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
84.6B USD 5.9 18.5 17.7 20
AU
CSL Ltd
ASX:CSL
84.8B AUD 3.6 18.9 12.7 15.9
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
48.1B USD 15 1 104 148.8 180.4
P/S Multiple
Revenue Growth P/S to Growth
FR
Biophytis SA
PAR:ALBPS
Average P/S: 9 195 226.6
Not Available
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
57 882 330.4
140%
413 445.2
FR
Pharnext SCA
OTC:PNEXF
34 067 817
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.5
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.8
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.2
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10
10%
1
US
E
Epizyme Inc
F:EPE
2 067.9
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.9
6%
1
AU
CSL Ltd
ASX:CSL
3.6
5%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
15
46%
0.3
P/E Multiple
Earnings Growth PEG
FR
Biophytis SA
PAR:ALBPS
Average P/E: 197.5
Negative Multiple: -0.3
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
Negative Multiple: -3 974 986 N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 919.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
165.8
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.8
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.6
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
32
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -527.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.5
10%
1.8
AU
CSL Ltd
ASX:CSL
18.9
11%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 104
N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Biophytis SA
PAR:ALBPS
Average EV/EBITDA: 35.6
Negative Multiple: -0.6
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
Negative Multiple: -3 900 678.1 N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 621.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.1
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.5
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -574.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.7
11%
1.6
AU
CSL Ltd
ASX:CSL
12.7
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
148.8
N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
FR
Biophytis SA
PAR:ALBPS
Average EV/EBIT: 42
Negative Multiple: -0.5
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
Negative Multiple: -3 891 995.3 N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 378 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.9
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.6
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -559.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
20
13%
1.5
AU
CSL Ltd
ASX:CSL
15.9
11%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
180.4
N/A N/A